2-(4-(Bromomethyl)-2-chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

1,3-Dimethyl-1H-pyrazol-5-ol, 95.0%, 100g

1,3-Dimethyl-2-fluoro-5-iodobenzene, 98+%, 1g

Ethyl 4-Nitropyrrole-2-carboxylate>98.0%(GC)(T)5g

(2-Fluoro-4-isopropoxyphenyl)boronic acid, 95.0%, 5g

Flacons à fond rond double col, 4000 ml, 29/32, 29/32, 1 pièce

(2S,3S)-3-(((S)-1-(Isopentylamino)-4-methyl-1-oxopentan-2-yl)carbamoyl)oxirane-2-carboxylic acid, 95%, 1mg

4-Fluoro-2-(trifluoromethyl)phenol, 99.0%, 1g

1-Methyl-1H-indole-7-carbaldehyde, 97.0%, 1g

(R,S)-Boc-2-amino-4,4,4-trifluoro-butyric acid, 99.0%, 1g

Kynurenic acid, 98.0%, 100mg

7-(4-methylpiperazin-1-yl)-1H,4H-pyrido[3,2-d]pyrimidin-4-one, 98%, 100mg

2-(4-Bromophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol, 98%, 250mg